US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist
  • 51.400
  • +0.250+0.49%
Close Dec 20 16:00 ET
  • 52.550
  • +1.150+2.24%
Post 20:01 ET
5.39BMarket Cap40.79P/E (TTM)

Corcept Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corcept Therapeutics Q3 2024 Earnings Date

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
171.97M
182.55M
+10.57M
Beat Est.
+39.13%
+47.69%
+6.15%
EPS
0.28
0.41
+0.13
Beat Est.
+0.71%
+46.43%
+45.39%
Analyst Rating
Strong Buy

Dec 22, 2024

Corcept Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 189.067M--
--2024/Q4-- / 198.881M--
Oct 30, 20242024/Q3182.546M / 171.971M--
Jul 29, 20242024/Q2163.796M / 155.217M--
May 1, 20242024/Q1146.808M / 141.202M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 189.067M--
--2024/Q4-- / 198.881M--
Oct 30, 20242024/Q3182.546M / 171.971M--
Jul 29, 20242024/Q2163.796M / 155.217M--
May 1, 20242024/Q1146.808M / 141.202M--

Unlock Free Earnings Estimates

Corcept Therapeutics Earnings Reports

  • Corcept Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 31 04:20

  • Corcept Therapeutics | 8-K: CORCEPT THERAPEUTICS ANNOUNCES THIRD QUARTER FINANCIAL RESULTS, POSITIVE RESULTS FROM PHASE 3 GRADIENT TRIAL IN PATIENTS WITH CUSHING'S SYNDROME AND PROVIDES CORPORATE UPDATE

    Oct 31 04:13

  • Corcept Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 30 04:16

  • Corcept Therapeutics | 8-K: CORCEPT THERAPEUTICS ANNOUNCES SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

    Jul 30 04:15

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data